HUMAN AMNIOTIC FLUID-DERIVED MESENCHYMAL STEM CELLS: FEATURES AND DIFFERENTIATION POTENTIAL

Monika Glemžaitė1, Sandra Baronaitė1, Aistė Zentelytė1, Jūratė Savickienė1, Natalija Krasovskaja2, Audronė Arlauskienė2, Rūta Navakauskienė1

1 Department of Molecular Cell Biology, Institute of Biochemistry, Life Sciences Centre, Vilnius University, Lithuania

2 Clinic of Obstetrics and Gynaecology, Faculty of Medicine, Vilnius University, Lithuania

Human amniotic fluid-derived mesenchymal stem cells (AF-MSCs) are a new potential stem cell source for regenerative medicine and therapy. These cells are obtained from amniotic fluid by amniocentesis from pregnant women under the necessity of prenatal diagnostics. Amniotic fluid is known to contain multiple cell types derived from the developing foetus and extra-embryonic tissues including foetal skin, placenta membranes, epithelial and mucosa of foetal digestive, respiratory and urinary tract [1]. Among these, there is a fraction of cells exhibiting stem-cell like properties and characteristics of mesenchymal stem cells that were termed amniotic fluid-derived mesenchymal stem cells [2]. AF-MSCs have high proliferation and self-renewal potential and are able to differentiate towards multiple lineages in vitro, such as osteogenic, adipogenic, myogenic, neurogenic, etc. They show no evident antigenicity and tumorigenicity and can be obtained securely and avoiding ethical issues related to embryonic stem (ES) cells [3]. Considering these features, AF-MS cells are a promising subject for researches in vitro as well as in vivo.

The aim of our work was to characterize human AF-MS cells phenotypically, genetically and to assess their differentiation potential.

AF-MSCs were obtained from second trimester amniotic fluid from healthy women who needed prenatal diagnostics but no foetus abnormalities were detected by genetic analysis (protocols approved by the Ethics Committee of Biomedical Research of Vilnius District, No 158200-123-428-122). They were evaluated phenotypically as having typical spindle shape. Flow cytometry analysis revealed that AF-MS cells are strongly positive for mesenchymal cell surface markers CD105, CD90 and CD44 and negative for hematopoietic marker CD34 (Fig. 1). These cells also expressed pluripotency markers of stem cells, such as Oct4, Nanog, Sox2 and Rex1 as determined by RT-qPCR. AF-MSCs were also confirmed for their multilineage differentiation potential towards adipogenic, myogenic, neurogenic [4], osteogenic [5] and cardiomyogenic lineages by cell staining and expression of genes-markers.

Figure 1
Fig. 1. Characterization of human amniotic fluid-derived stem cells.

In conclusion, our results complement knowledge about mesenchymal stem cells derived from human amniotic fluid confirming that these cells can be considered as multipotent stem cells and used for successful differentiation in vitro towards various lineages. This provides new insights for further investigations of human AF-MSCs and their applications in cell therapy and regenerative medicine.


[1] De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007 Jan; 25(1):100-6. Epub 2007 Jan 7.

[2] Prusa AR, Marton E, Rosner M, Bernaschek G, Hengstschlager M. Oct-4-expressing cells in human amniotic fluid: a new source for stemcell research? Hum Reprod. 2003 Jul; 18(7):1489-93.

[3] Roubelakis MG, Pappa KI, Bitsika V, Zagoura D, Vlahou A, Papadaki HA, et al. Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells. Stem Cells Dev. 2007 Dec; 16(6):931-52.

[4] Savickiene J, Treigyte G, Baronaite S, Valiuliene G, Kaupinis A, Valius M, Arlauskiene A, Navakauskiene R. Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis. Stem Cells Int. 2015; 2015:319238. doi: 10.1155/2015/319238. Epub 2015 Aug 17.

[5] Glemžaitė M, Navakauskienė R. Osteogenic Differentiation of Human Amniotic Fluid Mesenchymal Stem Cells Is Determined by Epigenetic Changes. Stem Cells Int. 2016; 2016:6465307. Epub 2016 Oct 12.